Trials / Recruiting

RecruitingNCT07345923

Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria

Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria in Intensive Care

Status: Recruiting
Phase: —
Study type: Observational
Enrollment: 1,000 (estimated)

Sponsor: University Hospital, Strasbourg, France · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

The objective of the research is to evaluate the value of testing for ESBL carriage by rectal swab to predict the risk of ESBL-producing Enterobacteriaceae infections in intensive care.

Conditions

Infections, Enterobacteriaceae

Timeline

Start date: 2025-10-06
Primary completion: 2027-04-01
Completion: 2027-04-01
First posted: 2026-01-16
Last updated: 2026-01-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07345923. Inclusion in this directory is not an endorsement.